A comparison of heparin without glycoprotein IIb/IIIa inhibition versus bivalirudin in elective percutaneous coronary intervention

被引：0
|
作者：
Gade, Christopher L. F. [1 ]
Feldman, Dmitny N. [1 ]
Ross, Michael [1 ]
Polin, Nichole [1 ]
Bergman, Geoffrey [1 ]
Wong, S. Chiu [1 ]
Minutello, Robert M. [1 ]
机构：
[1] Presbyterian Hosp, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B87 / B87
页数：1
相关论文
共 50 条
  • [1] Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors
    Abtahian, Farhad
    Waldo, Stephen
    Jang, Ik-Kyung
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (03) : 390 - 396
  • [2] Comparison of heparin plus IIb/IIIa inhibition versus bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial
    Stone, Gregg W.
    White, Harvey D.
    Ohman, E. M.
    Bertrand, Michel E.
    Lincoff, A. M.
    McLaurin, Brent T.
    Cox, David A.
    Pocock, Stuart J.
    Ware, James H.
    Colombo, Antonio
    Mehran, Roxana
    Moses, Jeffrey W.
    [J]. CIRCULATION, 2006, 114 (18) : 551 - 551
  • [3] Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
    Cohen, DJ
    Lincoff, AM
    Lavelle, TA
    Chen, HL
    Bakhai, A
    Berezin, RH
    Jackman, D
    Sarembock, IJ
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1792 - 1800
  • [4] Economic evaluation of bivalirudin with or without glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for early invasive management of acute coronary syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    York, Meghan
    Reynolds, Matthew R.
    McLaurin, Brent T.
    Cox, David A.
    Schneider, Elizabeth A.
    Shi, Chunxue
    Walczak, Joshua
    Vachon, David A.
    Berezin, Ronna H.
    Meman, Roxana
    Orman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A219 - A219
  • [5] Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    Shi, Chunxue
    Dunn, Elizabeth S.
    Reynolds, Matthew R.
    York, Meghan
    Walczak, Joshua
    Berezin, Ronna H.
    Mehran, Roxana
    McLaurin, Brent T.
    Cox, David A.
    Ohman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (22) : 1758 - 1768
  • [6] A pooled analysis of 3 trials of Bivalirudin versus Heparin and Glycoprotein IIb/IIIa inhibitors during Percutaneous Coronary Intervention
    Kalyanasundaram, Arun
    Sartorius, Jennifer
    Scott, Thomas
    Blankenship, James C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 79I - 80I
  • [7] Bleeding risk and outcomes of bivalirudin versus glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated heparin in elective percutaneous coronary intervention
    Steinberg, Daniel H.
    Shah, Palak
    Slottow, Tina L. Pinto
    Kinnaird, Tim
    Roy, Probal K.
    Buch, Ashesh N.
    Javaid, Aamir
    Okabe, Teruo
    Smith, Kimberly A.
    Xue, Zhenyi
    Suddath, William
    Kent, Kenneth M.
    Satler, Lowell F.
    Satler, Lowell F.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    [J]. CIRCULATION, 2007, 116 (16) : 630 - 630
  • [8] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [9] Can bivalirudin and provisional GP IIb/IIIa blockade REPLACE heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention?
    Doggrell, S
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1431 - 1433
  • [10] Bivalirudin versus heparin, without glycoprotein inhibition, in percutaneous coronary intervention: A comparison of ischemic and hemorrhagic outcomes over 10 years
    Chaudry, Hannah I.
    Curran, Theodore B.
    Andrus, Bruce W.
    Conley, Sheila M.
    DeVries, James T.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (03) : 338 - 342
12345